Sigurd Berven, MD (University of California San Francisco) and Michael Y. Wang, MD, FACS (The University of Miami) discuss the practice of and future of pedicle subtraction osteotomies.

Disclosures:

Berven, Sigurd H.: Consulting: Innovasis (B), Medicrea (C), Medtronic (C); Fellowship Support: Globus Medical (D); Grants: AO Spine (E, Paid directly to institution/employer), Globus (D, Paid directly to institution/employer); Private Investments: Green Sun Medical (50,000 Shares); Royalties: Stryker (F); Scientific Advisory Board: Globus Medical (Stock options); Speaking and/or Teaching Arrangements: Medtronic (B), Stryker Spine (B); Stock Ownership: Globus Medical (25,000 Shares), Providence Medical (2,500 Shares); Trips/Travel: Scoliosis Research Society (Travel Expense Reimbursement, Paid directly to institution/employer).

Wang, Michael Y.: Royalties: DePuy Synthes Spine (F); Stock Ownership: ISD (<1%), Medical Device Partners (<1%); Consulting: Stryker (C), Spineology (C), K2M (C), DePuy Synthes (C); Scientific Advisory Board: Vallum (A).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+